(NTLA) Intellia Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Intellia Therapeutics | (NTLA) share price targets
Complete technical analysis of Intellia Therapeutics (NTLA) by charts plus indicators, forecast predictions and share price targets for Intellia Therapeutics (NTLA)
Intellia Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-25 View latest technical analysis
10 day averaged volume of Intellia Therapeutics is 1707440
Date | Daily Closing Price | Open | High | Low | Volume |
25 Tue Jun 2024 | 24.00 | 24.70 | 24.84 | 23.97 | 0.978 times |
24 Mon Jun 2024 | 25.00 | 26.21 | 26.93 | 24.80 | 1.534 times |
21 Fri Jun 2024 | 24.22 | 24.25 | 24.41 | 23.45 | 1.756 times |
20 Thu Jun 2024 | 24.15 | 24.50 | 24.64 | 23.93 | 0.773 times |
18 Tue Jun 2024 | 24.80 | 25.13 | 25.17 | 24.58 | 0.928 times |
18 Tue Jun 2024 | 24.80 | 25.13 | 25.17 | 24.58 | 0.928 times |
17 Mon Jun 2024 | 25.17 | 25.00 | 25.62 | 24.75 | 0.606 times |
14 Fri Jun 2024 | 25.15 | 25.88 | 26.17 | 25.01 | 0.604 times |
13 Thu Jun 2024 | 25.96 | 25.85 | 26.52 | 25.42 | 0.706 times |
12 Wed Jun 2024 | 25.85 | 24.80 | 26.98 | 24.51 | 1.345 times |
My analysis of stock is bullish for shortterm, and stock might move up till 25.1 or till 26.6. Use a stoploss of 23.84 and if this stock hits its stoploss, then it can fall down till 22.56
Share price targets for Intellia Therapeutics (NTLA)
Target Type | Value |
Downside Target | 19.37 |
Downside Target | 21.31 |
Downside Target | 22.03 |
Downside Target | 23.45 |
Upside Target | 25.17 |
Upside Target | 26.93 |
Upside Target | 26.98 |
Upside Target | 27.17 |
Upside Target | 27.46 |
Upside Target | 34.01 |
Upside Target | 34.87 |
Intraday share price targets for Intellia Therapeutics (NTLA)
Target Type | Value |
Downside Intraday Target | 23 |
Downside Intraday Target | 22.01 |
Upside Intraday Target | 25.96 |
Upside Intraday Target | 27.93 |
Upside Intraday Target | 24.97 |
Weekly technical analysis of Intellia Therapeutics (NTLA)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Tue Jun 2024 | 24.00 | 26.21 | 26.93 | 23.97 | 0.727 times |
21 Fri Jun 2024 | 24.22 | 25.13 | 25.17 | 23.45 | 2.254 times |
18 Tue Jun 2024 | 24.80 | 25.00 | 25.62 | 24.58 | 0.36 times |
14 Fri Jun 2024 | 25.15 | 22.53 | 26.98 | 22.11 | 0.613 times |
07 Fri Jun 2024 | 22.73 | 22.60 | 24.33 | 22.03 | 1.342 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Intellia Therapeutics (NTLA)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Tue Jun 2024 | 24.00 | 22.60 | 26.98 | 22.03 | 1.001 times |
31 Fri May 2024 | 21.38 | 21.33 | 27.17 | 21.31 | 1.199 times |
30 Tue Apr 2024 | 21.40 | 27.43 | 27.46 | 19.37 | 0.99 times |
28 Thu Mar 2024 | 27.51 | 32.42 | 34.01 | 26.06 | 0.675 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Intellia Therapeutics (NTLA)
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term and the buy signal is strong.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 24.87 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term and the buy signal is strong.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 24.87 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.